Saianand Commercial Limited is an India-based company. The Company is not engaged in any activity. It does not generate any revenue. The management is looking for an opportunity to make the Company operational.

Employees

Sector

Investment Holding Companies

More about the company

Quotes

Date	Price	Change	Volume
24/26/24	₹0.2200	+10.00%	1,74,060
23/26/23	₹0.2000	-4.76%	2,37,498
22/26/22	₹0.2100	0.00%	1,53,007
21/26/21	₹0.2100	0.00%	2,25,447
18/26/18	₹0.2100	0.00%	2,69,362

Delayed Quote Bombay S.E.

More quotes

Market Closed - Bombay S.E. 03:32:34 24/09/2026 pm IST			5-day change	1st Jan Change
0.2200 ^INR	+10.00%		+4.76%	-26.67%

06/08	Saianand Commercial Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
15/05	Saianand Commercial Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Market Cap	5Cr 5L 5L 4L 4L 7L 7L 51.65L 20.03L 2.55Cr 19.56L 19.13L 8.28Cr	P/E 2025	22.4x	P/E 2026	27.5x
Enterprise Value	4.98Cr 5L 5L 4L 4L 7L 7L 51.49L 19.97L 2.54Cr 19.5L 19.07L 8.25Cr	EV / Sales 2025	4.25x	EV / Sales 2026	-
Free-Float	90.12%	Yield 2025 *	-	Yield 2026	-

06/08	Saianand Commercial Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
15/05	Saianand Commercial Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
30/01	Saianand Commercial Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
06/11	Saianand Commercial Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
28/25/28	Saianand Commercial Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
21/25/21	Saianand Commercial Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025	CI
31/25/31	Saianand Commercial Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	CI
28/25/28	Swagtam Trading & Services Limited announced that it expects to receive INR 61.904375 million in funding from Jalees Commercial Limited, Shree Ganesh Bio-Tech Limited, Amerise Biosciences Limited, Saianand Commercial Limited and other investors	CI
16/25/16	Saianand Commercial Limited Approves Resignation of Komal Chauhan as Independent Director	CI
12/24/12	Saianand Commercial Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	CI
10/24/10	Kunal H. Kothari, Prachi and Tejas K. Rathod completed the acquisition of 67.61% stake in Lucent Industries Limited from a group of shareholders.	CI
13/24/13	Saianand Commercial Limited Reports Earnings Results for the First Quarter Ended June 30, 2024	CI
30/24/30	Saianand Commercial Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI

1 day	+10.00%
1 week	+4.76%
Current month	+10.00%
3 months	-4.35%
6 months	-12.00%
Current year	-26.67%

Saianand Commercial Limited Share Price

Stocks

SAICOM

INE092G01024

Investment Holding Companies

Valuation: Saianand Commercial Limited

Chart: Saianand Commercial Limited

Latest news: Saianand Commercial Limited

Quotes and Performance

Price Extremes

Managers and Directors: Saianand Commercial Limited

Shell Companies

Financials

Company Profile

Quotes

1 week	0.2	0.22
1 month	0.2	0.22
Current year	0.2	0.31
1 year	0.2	0.39
3 years	0.2	0.95
5 years	0.2	1.04
10 years	0.2	1.04

Manager	Title	Age	Since
Milanbhai Rameshbhai Khatri DFI	Director of Finance/CFO	44	26/12/2023
Bhagyashree Vinayak SEC	Corporate Secretary	-	30/05/2022

Director	Title	Age	Since
Gaurangkumar V. Vaishnav BRD	Director/Board Member	34	07/03/2019
Narendra Kumar Vaniya BRD	Director/Board Member	34	05/08/2022
Kajal Milan Khatri BRD	Director/Board Member	39	26/12/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAIANAND COMMERCIAL LIMITED	+10.00%	+4.76%	-35.29%	-51.11%	5L
CHURCHILL CAPITAL CORP XI	-3.85%	+1.16%	-	-	71Cr
CENTIEL AG	-4.82%	+0.68%	+272.33%	-74.92%	62Cr
DRUGS MADE IN AMERICA ACQUISITION II CORP.	-0.10%	-0.10%	-	-	65Cr
BAIN CAPITAL GSS INVESTMENT CORP.	-0.19%	+0.49%	-	-	60Cr
CHURCHILL CAPITAL CORP XII	+0.19%	-0.05%	-	-	59Cr
CANTOR EQUITY PARTNERS IV, INC.	+0.05%	-0.87%	+0.93%	-	59Cr
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	-0.09%	+0.18%	-	-	55Cr
NEW AMERICA ACQUISITION I CORP.	-0.10%	-0.35%	-	-	50Cr
Average	+0.12%	+0.64%	+79.32%	-63.01%	53.46Cr
Weighted average by Cap.	-1.21%	+1.45%	+139.68%	-74.90%

	2025	2026
Net sales	2.48Cr 3L 2L 2L 2L 4L 4L 25.58L 10L 1.26Cr 10L 9L 4.1Cr	-
Net income	35.57L 37.07T 32.57T 30.66T 28.05T 52.42T 52.84T 4L 1L 18.12L 1L 1L 58.9L	17.37L 18.1T 15.9T 14.97T 13.7T 25.6T 25.8T 2L 69.59T 9L 67.97T 66.49T 28.76L
Net Debt	2.57Cr 3L 2L 2L 2L 4L 4L 26.52L 10.28L 1.31Cr 10.04L 10L 4.25Cr	-2L -1.57T -1.38T -1.3T -1.19T -2.23T -2.24T -15.6T -6.05T -76.9T -5.91T -5.78T -3L